Benjamin Blum
InvestorVenture Partner at Hyperplane Venture Capital
Boston, Massachusetts
Writes $250K – $3M checks · typically $1.5M
Experience
- IAVIDirector, Data Science and Bioinformaticscurrent2025 — present
- Hyperplane Venture CapitalVenture Partnercurrent2018 — present
- Odyssey TherapeuticsPrincipal Data Scientist2022 — 2025
- Newco/Inzen/Sonata (Flagship Pioneering)Senior Data Scientist2021 — 2022
- Boston University School of MedicineResearcher (Graduate Student, Post-Doc, Consulting)2014 — 2021
- MPM CapitalGraduate Student Intern2018 — 2019
- Adnexus Therapeutics (Bristol-Myers Squibb)Adnexus Therapeutics2009 — 2014
Education
- Boston University School of MedicineDoctor of Philosophy - Ph.D., Computational Network Systems Biology
- Dartmouth CollegeBachelor of Arts (A.B.)
Colleagues at Hyperplane Venture Capital
Abigail Risse
Analyst at Hyperplane Venture Capital
Anthony Tayoun
Principal at Hyperplane Venture Capital
Blake Billiet
Principal at Hyperplane Venture Capital
Brendan Kohler
Co-Founder and CTO at Hyperplane Venture Capital
Chris Curtis
Vice President, Finance & Portfolio Management at Hyperplane Venture Capital
Jack Klinck
Investor at Hyperplane Venture Capital
John Murphy
Co-Founder & Partner at Hyperplane Venture Capital
Megan Sabel
COO & Head of Investor Relations at Hyperplane Venture Capital
Network1
Investors connected to Benjamin in public investor directories — a warm-intro map.
Frequently asked questions
- Where does Benjamin Blum work?
- Benjamin Blum is Venture Partner at Hyperplane Venture Capital.
- What check size does Benjamin Blum write?
- Benjamin Blum typically writes checks of $250K – $3M.
Same school
Also attended Boston University School of Medicine8
Parth DesaiPartner at Flare Capital PartnersBridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear CapitalMonica JainVenture Partner at Wavemaker Three-Sixty HealthSelene ParekhDigital Health Advisor at Excelerate Health VenturesJai ParekhDigital Health Advisor at Excelerate Health VenturesTom InselCo-Founder, Mindstrong, NIH at AIF
+ 2 more
Also attended Dartmouth College398
Tomasz TunguzFounder & General Partner at Theory VenturesScott SandellExecutive Chairman & Chief Investment Officer at NEAJames DetweilerVP of Investments at Felicis VenturesBen RobbinsInvestor at GV (Google Ventures)Mounisha AnumoluInvestor at GV (Google Ventures)Ren RileyAdvisor at Oak Investment Partners
+ 392 more
Shared employers
Also worked at IAVI1
Also worked at Odyssey Therapeutics2
Also worked at Boston University School of Medicine2
Also worked at MPM Capital36
Christiana BardonManaging Partner of MPM BioImpact, leading the firm's public market investingDetlev BiniszkiewiczManaging Director at MPM BioImpactLuke EvninAdvisor at MPM BioImpactTodd FoleyManaging Director at MPM BioImpactAnsbert K. GadickeManaging Partner at MPM BioImpactDavid KoleskyPrincipal at MPM BioImpact
+ 30 more






























